Cspc Pharmaceutgr Adr4 Stock Beneish M Score
| CVGU Stock | EUR 2.30 0.02 0.88% |
CSPC |
At this time, CSPC PHARMACEUTGR's M Score is inapplicable. The earnings manipulation may begin if CSPC PHARMACEUTGR's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by CSPC PHARMACEUTGR executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of CSPC PHARMACEUTGR's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
About CSPC PHARMACEUTGR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSPC PHARMACEUTGR ADR4's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSPC PHARMACEUTGR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSPC PHARMACEUTGR ADR4 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Stock
CSPC PHARMACEUTGR financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC PHARMACEUTGR security.